Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

CareTrust REIT's planned $817 million merger with Care REIT indicates immediate financial accretion, which is a strong positive signal for the company's future earnings potential. The merger also presents an opportunity for CareTrust REIT to effectively leverage its under-utilized balance sheet, enhancing its financial flexibility and growth prospects. This strategic move into the UK market further diversifies its portfolio, reinforcing its position within the healthcare real estate sector.

Bears say

CareTrust REIT is facing potential headwinds due to tenant challenges that may hinder earnings growth, impacting financial stability negatively. The company's initial lease yield of 8.1% is notably lower than the approximately 10% cash lease yields reported by other U.S. REIT peers, which raises concerns about its competitive positioning in the market. Additionally, tax leakage associated with profit repatriation could further diminish the overall investment yield by an estimated 50 to 100 basis points, contributing to a less favorable outlook for the company's financial performance.

CareTrust REIT (CTRE) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 8 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.